AbolerIS Pharma

📍 Gosselies, Belgium🗓 Founded 2019👥 16 employees💰 Last funded Jul 2023
Biotechnology Research🌐 aboleris-pharma.com
Website LinkedIn
Founded by a team with a long cutting-edge translational expertise in regulatory T cells and mechanisms of tolerance, AbolerIS Pharma is developing novel and unique therapeutic approaches to finely regulate the immune system by inducing immune tolerance and preserving useful immune responses in inflammatory, autoimmune, and degenerative diseases.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
2
Frequently asked questions
Who invested in AbolerIS Pharma?
AbolerIS Pharma has 2 investors on record on gritt.io, 2 mid-stage.
When did AbolerIS Pharma last raise funding?
The most recent investment in AbolerIS Pharma recorded on gritt.io was in July 2023.
When was AbolerIS Pharma founded?
AbolerIS Pharma was founded in 2019.
What industry is AbolerIS Pharma in?
AbolerIS Pharma operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is AbolerIS Pharma based?
AbolerIS Pharma is headquartered in Gosselies, Belgium.